Gilead Sciences, Inc. (GILD) Message Board

Moderators:

Search This Board:

Created: 04/30/2009 09:47:00 AM - Followers: 168 - Board type: Free - Posts Today: 0

GILD Investor Relations
http://investors.gilead.com/events?c=69964&p=irol-calendar
Viral Disease Pipeline Phase 1 Phase 2 Phase 3 NDA/BLA/MAA HIV Biktarvy HIV treatment pediatric1 Capsid inhibitor (GS-6207)
HIV HTE HIV treatment naïve Vesatolimod (GS-9620, TLR-7 agonist) HIV cure Elipovimab (GS-9722, bNAb)
HIV cure HBV Selgantolimod
(GS-9688,TLR-8 agonist) HBV cure PD-L1 inhibitor (GS-4224) HBV cure 1 Biktarvy HIV treatment pediatric label extension.
2 Registrational for heavily treatment-experienced (HTE) patients.

http://investors.gilead.com/stock-information/stock-quote-chart
http://investors.gilead.com/stock-information/historical-price-lookup

GILEAD SCIENCES, INC.

333 Lakeside Drive

Foster City, CA 94404

http://www.gilead.com (650) 574-3000

https://www.otcmarkets.com/stock/GILD/disclosure

https://www.otcmarkets.com/stock/GILD/news

https://www.otcmarkets.com/stock/GILD/security

https://www.otcmarkets.com/stock/GILD/profile

https://www.otcmarkets.com/stock/GILD/quote

https://www.otcmarkets.com/stock/GILD/overview

PER IHUB MGMT

02-07-2021
DISCLAIMER: ONLY FOR MICK
https://investorshub.advfn.com/boards/profilea.aspx?user=1012
*The Board Monitor and herewithin , are not licensed brokers and assume NO responsibility for actions,
investments,decisions, or messages posted on this forum.
CONTENT ON THIS FORUM SHOULD NOT BE CONSIDERED ADVISORY NOR SOLICITATION
AUTHORS MAY HAVE BUYS OR SELLS WITH THE COMPANIES MENTIONED IN TRADING POSTERS SHOULD DUE DILIGENT BUYING OR SELLING.
ALL POSTING SHOULD BE CONSIDERED FOR INFORMATION ONLY. WE DO NOT RECOMMEND ANYONE BUY OR SELL ANY SECURITIES POSTED HEREWITHIN.
ANY trade entered into risks the possibility of losing the funds invested.
• There are no guarantees when buying or selling any security.Any

PlusOneCoin Top Posts									Free PlusOneCoin
No plusone'd posts yet. Be the first!

Post	Subject		Older
#4837	Gilead has underperformed for so long, given the	Zeppo	06/15/2022 11:59:24 AM
#4836	GILD details why the purportedly-positive Trodelvy data from	DewDiligence	06/04/2022 06:14:26 PM
#4835	Gilead Sciences Inc (GILD)	mick	05/01/2022 04:27:31 PM
#4834	ZUMA-11. Improved CAR-T responses with 4-1BB agonist utomilumab	jondoeuk	04/28/2022 06:55:27 PM
#4833	Link to the audio recording https://investors.gilead.com/events/event-details/gi	jondoeuk	04/20/2022 05:49:51 PM
#4832	Oncology Deep Dive https://investors.gilead.com/static-files/332d0c81-fa18-44fa-	jondoeuk	04/19/2022 06:50:14 PM
#4831	ZUMA-12 https://www.nature.com/articles/s41591-022-01731-4	jondoeuk	03/23/2022 07:38:59 PM
#4830	GILD News: Gilead price target slashed at Barclays	mick	03/12/2022 03:03:59 PM
#4829	Gilead Sciences Inc (GILD)	mick	03/12/2022 03:03:28 PM
#4828	Gilead Sciences Inc (GILD)	mick	02/15/2022 04:33:38 PM
#4827	Gilead Sciences Inc (GILD)	mick	02/06/2022 05:27:48 PM
#4826	GILD owes ViiV* $1.25B+_3% royalty on_US Biktarvy sales,	DewDiligence	02/01/2022 07:04:10 PM
#4825	GILD 4Q21 results…	DewDiligence	02/01/2022 04:08:45 PM
#4824	https://www.otcmarkets.com/stock/GILD	mick	01/02/2022 06:12:00 PM
#4823	GILD vs BMY in LBCL CAR-T—who has the edge?	DewDiligence	12/13/2021 07:04:16 PM
#4822	https://www.otcmarkets.com/stock/GILD	mick	12/11/2021 07:17:35 PM
#4821	GILD and MTNB have been working on ORAL	dhbuzz	12/09/2021 11:13:41 AM
#4820	VIR/GILD start phase-2 trial testing quadruple regimen of	DewDiligence	12/09/2021 10:06:27 AM
#4819	I Agree: https://www.griproom.com/fun/pfizers-covid-pill-might-not-be-as-great-a	Michel	11/08/2021 07:09:56 AM
#4818	Showtime this week! Brilacidin is a BEAST. Remdesivir	Ultimate01	11/08/2021 07:05:18 AM
#4817	Gilead Sciences Inc (GILD)	mick	11/07/2021 12:27:25 PM
#4816	i think so they got ah good pipeline though	mick	11/07/2021 12:27:17 PM
#4815	http://www.ipharminc.com/press-release/2020/9/15/laboratory-testing-of-brilacidi	Michel	11/02/2021 07:33:38 AM
#4814	Mick, I think we are the only ones	slimhere	10/29/2021 10:36:58 AM
#4813	$15 under wow	mick	10/28/2021 05:11:11 PM
#4812	Gilead Sciences Inc (GILD)	mick	10/28/2021 05:10:40 PM
#4811	5PM, we'll see how close you are, I'm	slimhere	10/28/2021 03:09:44 PM
#4810	$gild should be over $80 to $100 imho	mick	10/10/2021 12:18:04 PM
#4809	$gild should be over $80 to $100 imho	mick	10/10/2021 12:18:04 PM
#4808	https://www.msn.com/en-us/health/medical/protein-found-on-infected-cells-protect	dhbuzz	09/28/2021 12:15:26 AM
#4807	Gilead Sciences Inc (GILD)	mick	09/22/2021 11:29:13 PM
#4806	NNVC encapsulates GILD’s Remdesivir, in what seems to	north40000	09/21/2021 12:47:28 PM
#4805	north, This is all on Fauci - proving	jasbg	09/19/2021 06:02:58 AM
#4804	European study finds that Gilead's Covid-19 antiviral remdesivir	north40000	09/18/2021 04:48:40 PM
#4803	Oral version of Gilead's remdesivir demonstrates promising preclinical results	dhbuzz	09/15/2021 09:33:36 AM
#4802	iT STARTED IN LATE 2020...https://www.matinasbiopharma.com/investors/news-events	dhbuzz	08/30/2021 09:26:45 AM
#4801	https://www.griproom.com/fun/gilead-and-matinas-may-have-beaten-covid-19	dhbuzz	08/30/2021 09:23:38 AM
#4800	I BELIEVE GILD is working with MTNB on this.	dhbuzz	08/30/2021 09:20:46 AM
#4799	https://finance.yahoo.com/news/gilead-sciences-wins-reversal-1-154757453.html "... A U.S. ap	north40000	08/26/2021 05:18:43 PM
#4798	Gilead Sciences Inc (GILD)	mick	08/14/2021 11:59:48 AM
#4797	Gilead Sciences Inc (GILD)	mick	07/10/2021 10:56:45 PM
#4796	Interesting article…	Newc	06/26/2021 11:59:44 PM
#4795	Gilead Sciences Inc (GILD)	mick	05/26/2021 12:11:00 PM
#4794	Is GILD's remdesivir relevant to this COVID-19 Vascular	north40000	05/03/2021 05:42:33 PM
#4793	www.stockscores.com/chart.asp?TickerSymbol=GILD&TimeRange=180&Interval=d&	mick	05/02/2021 07:37:36 PM
#4792	http://www.ipharminc.com/press-release/2020/9/15/laboratory-testing-of-brilacidi	Stowe	04/28/2021 03:59:13 PM
#4791	The tested cocktails still require (intravenous) remdesivir to	DewDiligence	04/28/2021 03:50:51 PM
#4790	Add some of this.https://www.sciencedaily.com/releases/2021/04/210427113805.htm	Stowe	04/28/2021 03:44:41 PM
#4789	Another step in the right direction:	tikotiko	04/25/2021 02:27:25 PM
#4788	More news about Redemsideath’s suspension:	tikotiko	04/20/2021 08:41:33 PM
Post	Subject		Older

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

GILD News: Which Biotech Stock is the Street More Bullish on?	06/29/2022 04:28:18 AM
GILD News: Kite’s CAR T-cell Therapy Yescarta® Granted European Marketing Authorization for the Treatment of Relapsed or Refractory Follicular Lymphoma	06/28/2022 06:00:00 AM
GILD News: Gilead Resubmits New Drug Application to U.S. Food and Drug Administration for Lenacapavir, an Investigational, Long-Acting HIV-1 Capsid Inhibitor	06/27/2022 04:30:00 PM
GILD News: Gilead Endorses The Kigali Declaration On Preventing, Controlling and Eliminating Neglected Tropical Diseases	06/27/2022 09:00:00 AM
GILD News: Gilead Gets CHMP Backing for Lenacapavir in Multi-Drug Resistant HIV	06/24/2022 09:03:00 AM

Quotes:

IHub:

GILEAD SCIENCES, INC.

Detailed Quote

No plusone'd posts yet. Be the first!